47 /100
MEDIUM RISK
Score updated Jul 14, 2026

ATII — Archimedes Tech SPAC Partners II Co. Dilution Risk Tracker

Track ATII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATII — Get alerts when the score changes →

As of July 14, 2026, Archimedes Tech SPAC Partners II Co. (ATII) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Archimedes Tech SPAC Partners II Co. has a market capitalization of $332.00M, 29.59M shares outstanding, 5 institutional holders tracked. Key dilution vectors include 11.92M outstanding warrants, approximately 18 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
37
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
📜 Warrant Exercise 60%
• Massive warrant overhang: 40% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track ATII — Get forecast alerts →

💹 Market Data

Market Cap$332.00M
Shares Outstanding29.59M
Float21.81M
Cash$1.08M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 51.8% shares (2026Q1 vs prior)
5 institutional holders · 108.4K shares
#1 JPMORGAN CHASE & CO 50.0K shares
#2 JANE STREET GROUP, LLC 46.1K shares
#3 Clear Street Group Inc. 10.0K shares
+ 2 more holders Sign up free to view →

📉 Short Interest

Short Interest36.1K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
8-K 8K EVENT Apr 20, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ATII Shareholders

Archimedes Tech SPAC Partners II Co. (ATII) has a DilutionScore of 47/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 11.9M outstanding warrants for ATII. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: ATII has approximately 18 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ATII in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for ATII alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track ATII Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATII — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ATII
📊 ATII FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ATII Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.